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Genome-wide association studies have identified genetic variation contributing to complex
disease risk. However, assigning causal genes and mechanisms has been more challenging
because disease-associated variants are often found in distal regulatory regions with cell-type
specific behaviours. Here, we collect ATAC-seq, Hi-C, Capture Hi-C and nuclear RNA-seq
data in stimulated CD4+ T cells over 24 h, to identify functional enhancers regulating gene
expression. We characterise changes in DNA interaction and activity dynamics that correlate
with changes in gene expression, and find that the strongest correlations are observed within
200 kb of promoters. Using rheumatoid arthritis as an example of T cell mediated disease, we
demonstrate interactions of expression quantitative trait loci with target genes, and confirm
assigned genes or show complex interactions for 20% of disease associated loci, including
FOXO1, which we confirm using CRISPR/Cas9.
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It is now well established that the vast majority of SNPsimplicated in common complex diseases from genome-wideassociation studies (GWAS) are found outside protein coding
exons and are enriched in both cell type and stimulatory
dependent regulatory regions1,2. The task of assigning these
regulatory enhancers to their target genes is non-trivial. First, they
can act over long distances, often ‘skipping’ genes3. Second, they
can behave differently dependent on cellular context4,5, including
chronicity of stimulation6. To translate GWAS findings in com-
plex disease genetics, one of the pivotal tasks is therefore to link
the genetic changes that are associated with disease risk to genes,
cell types and direction of effect.
Popular methods to link these ‘disease enhancers’ to genes is
either to determine physical interactions, with methods such as
Hi-C7, use quantitative trait analysis4 or examine correlated
states8, with techniques such as ChIP-seq and ATAC-seq, linked
to gene expression. The vast majority of these studies, to date,
have investigated these epigenomic profiles at either discrete time
points9,10 (e.g., baseline and/or after stimulation), and/or by
combining data from different experiments (e.g., ATAC-seq and
Hi-C)9.
Over 100 genetic loci have been associated with rheumatoid
arthritis (RA), a T cell-mediated autoimmune disease. Of these,
14 loci have associated variants that are protein coding and 13
have robust evidence through expression quantitative trait locus
(eQTL) studies to implicate the target gene. The remainder is
thought to map to regulatory regions, with so far unconfirmed
gene targets, although we, and others, have previously shown
interactions with disease implicated enhancers and putative
causal genes3,11,12.
Here we have combined simultaneously measured ATAC-seq,
Hi-C, Capture Hi-C (CHi-C) and nuclear RNA-seq data in sti-
mulated primary CD4+ T cells (Fig. 1), to define the complex
relationship between DNA activity, interactions and gene
expression. We then go on to incorporate fine-mapped associated
variants from RA, and validate long range interactions with
CRISPR/Cas9, to assign SNPs, genes and direction of effect to
GWAS loci for this T cell-driven disease.
Results
High-quality data from sequenced libraries. A total of 116.7 ±
28.5 million reads per sample were mapped for RNA-seq by
STAR13 with alignment rates over 98% across six time points:
0 min, 20 min, 1 h, 2 h, 4 h and 24 h after stimulation with anti-
CD3/anti-CD28. A total of 76,359 ATAC-seq peaks were
obtained; 6287 peaks unique to unstimulated cells and 45,869
only appearing after stimulation. A total of 271,398 CHi-C
interactions were generated from the time course data and
interactions were retained as features when at least one time point
showed a significant interaction. Of these interactions, 94%
occurred within the same chromosome and 57% were within
5Mb of promoters.
Gene expression data demonstrated good correlation between
replicates (Supplementary Fig. 1a–d). From an initial FACS
analysis (Supplementary Table 1 and Supplementary Fig. 2a, b)
and comparison of RNA-seq data, we determined the initial T-
cell purity of the samples to be reproducibly high, around 94%
CD4+, displaying similar amounts of CD4+ memory and CD4+
naive (Supplementary Fig. 3a). To assess the amount of
stimulation, we explored markers of naivety, activation and
cytokine expression and confirmed a similar degree of stimulation
across all the samples (Supplementary Fig. 3b).
ATAC-seq peaks also demonstrated good quality and correla-
tion between replicates (Supplementary Fig. 4a–e) and enrich-
ment for both marks of enhancer activity (ChromHMM,
Supplementary Fig. 5a–d) and CTCF sites across all time points
(Supplementary Fig. 5e), with an increased amount of CTCF
occupancy in ATAC-seq peaks at topologically associating
domain (TAD) boundaries, as expected (Supplementary Fig. 5f).
Data consistency with previous studies. Comparison of ATAC-
seq peaks from CD4+ baseline (unstimulated) and 48 h after
stimulation peaks from a similar data set9 revealed strong
concordance (Supplementary Fig. 4f): 71% of peaks (21,549/
30,403) from unstimulated CD4+ T cells overlapped in
both data sets9, while 75% of peaks (22,911/30,593) from sti-
mulated CD4+ T cells (24 vs. 48 h post stimulation) over-
lapped9. We also observed a similar magnitude of increase in
the number of ATAC-seq peaks for merged unstimulated and
stimulated data.
Comparison of our CHi-C data with published data sets from
the same cell type and stimulation10, both unstimulated or
stimulated for 4 h, demonstrated good consistency (Supplemen-
tary Fig. 6a). When restricting all the interactions from both
unstimulated and stimulated to those that share the same baits,
we found 57% of interactions (27,794/48,570) to overlap (by at
least 1 bp) between our study and previously identified interac-
tions10 and this increases to 73% for interactions within 5Mb of
promoters (26,836/36,698) and 87% within 200 kb of promoters
(8,367/9,627). This strongly suggests that the interactions between
promoters and active enhancers within 200 kb are consistent,
robust and reproducible between studies. We found 22,126 genes
with evidence of CD4+ T-cell expression for at least one time
point in our RNA-seq data. We considered genes classified as
‘Persistent repressed’, ‘Early induced’, ‘Intermediate induced I’,
‘Intermediate induced II’ and ‘Late induced’ in a previous study4,
and found that these genes exhibited similar patterns of
expression in our RNA-seq data (Supplementary Fig. 1e–i).
Chromatin conformation dynamics. It is well established that
gene expression changes with time after stimulation in CD4+
T cells4 and we find similar changes to previous studies, with a
range of dynamic expression profiles corresponding to genes
activated early, intermediate or late, or repressed (Supplementary
Fig. 1e–i). However, it is less well established how chromatin
structure changes post stimulation, in the form of A/B com-
partments, TADs and individual interactions, or how enhancer
activity and open chromatin change over time.
Based on Hi-C matrices with resolutions of 40 kb, 1230 merged
TADs were recovered across all the time points with an average
size of 983.2 kb. Consistency of TADS across time points was
measured by the fraction of overlapping TADS (90% reciprocal),
over the number of TADs at each specified time point
(Supplementary Fig. 7a). On average between time point 0 and
4 h 84% of TADS intersect. When adding the 24 h TAD data, the
mean intersection reduces to 74%, illustrating more substantial
dynamic changes in TADs over longer times. Figure 2b shows the
stratum-adjusted correlation coefficient (SCC) between Hi-C data
sets14 and shows a slight but significant reduction in correlation
as the time separation of experiments increases, consistent with
our observations regarding TADs. SCC between replicates and
within replicates does not show clear differences, implying that
the changes in correlations are not due to batch effects.
We recovered 1136 A compartments and 1266 B compart-
ments merged across the time course data, with the maximum
compartment sizes being 39.5 and 34.5 Mb, respectively. Similar
to TADs, the consistency of compartments across time points was
measured by the fraction of overlapping compartments (90%
reciprocal) over the number of compartments at each specified
time point (Supplementary Fig. 7b, c). The same consistency was
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observed for compartments A and B. Figure 2c shows the
correlation between A/B compartment allocations, demonstrating
a slight but significant reduction between experiments as time
separation increases. Consistent B compartments and compart-
ments that changed over time from A to B were found to be
enriched for lamina associated domains when compared to ones
from a resting and activated T-cell line15 and genes with
repressed expression (Supplementary Fig. 8).
These results are broadly consistent with other studies,
demonstrating how the higher chromatin conformation states,
in the form of A/B compartments and TADS, are largely invariant
between cell types11. Here, we demonstrate similar levels of
consistency in a single cell-type post stimulation (Supplementary
Fig. 9a–c).
In contrast to the relative invariance of TADs and A/B
compartments, our CHi-C data, analysing interactions between
individual restriction fragments, showed a much greater degree of
dynamics. We used the Bayesian Information Criterion (BIC)16
and a χ2 test to compare a dynamic (Gaussian process) model to a
static model17 for CHi-C interaction count data across time. We
found 24% (63,843/271,398) of CHi-C links with evidence of
change over time (BICdynamic < BICstatic) and 7.5% of interactions
showed stronger evidence of change over time (20,224/271,398, χ2
test, P < 0.05), among which 24% (4837/20,224) are within 200 kb
of promoters.
Open chromatin dynamics. We compared a dynamic (Gaussian
process) and static model for ATAC-seq time course data to
identify changes in open chromatin across time and found 11%
(7852/74,583) of ATAC-seq peaks with evidence of change over
24 h (BICdynamic < BICstatic) with 2780 of these peaks showing
stronger evidence of change (χ2 test, P < 0.05). A heatmap of
ATAC-seq time course data (Fig. 3a) demonstrates six broad
patterns of change (Fig. 3b). Mapping of transcription factor
binding sites (TFBS) motifs under these broad clusters revealed a
strong enrichment of transcription factors known to be important
in CD4+ stimulation and differentiation. The AP-1 TFBS (e.g.,
BATF) motif was shown to be enriched in low to high activity,
whilst strong enrichment of ETS/RUNX1 TFBS was seen in
models of high to low activity, and a strong enrichment of CTCF
and BORIS motifs was observed in the models that demonstrated
transient dynamics before returning to baseline after 24 h. These
findings match those reported in a previous study of ATAC-seq
data in CD4+ T cells stimulated with anti-CD3/anti-CD289.
There it was demonstrated that the AP-1/BATF motif was enri-
ched in stimulated ATAC-seq peaks, ETS/RUNX in unstimulated
cells and CTCF/BORIS motifs were detected under the ‘shared’
unstimulated and stimulated peaks, closely matching our find-
ings. ATAC-seq peaks overlapping H3K27ac marks and without
CTCF binding are more likely to be gained over time (blue to red,
Supplementary Fig. 10a), a pattern not seen in ATAC-seq peaks
bound by CTCF without H3K27ac, although the distribution of
interactions from these two classes of peaks (gained or lost)
remains similar, with no bias seen in either category of peak
(Supplementary Fig. 10b). We found evidence that the increase in
ATAC-seq activity over time (e.g., Fig. 3b, cluster 1) corre-
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Fig. 1 Schematic of the study design. ATAC-seq, CHi-C and nuclear RNA-seq experiments were carried out for unstimulated and stimulated CD4+ T-cell
samples at time 0min, 20min, 1 h, 2 h, 4 h and 24 h. Time course profiles were created by aligning features (ATAC-seq peaks and CHi-C interactions)
across time and counting reads supporting each feature at each time point. Courtesy of Servier Medical Art licensed under a Creative Commons
Attribution 3.0 Unported license. https://smart.servier.com.
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Fig. 2 Illustration of Hi-C dynamics. a Hi-C interaction matrix (100 kb resolution) of replicate 1 for chr1 at time 0min (upper) with corresponding A/B
compartments (lower), where red lines represent positions of SNPs. b Correlation changes between Hi-C data with respect to differences between times,
where the dashed line is the fitted linear line for the correlation coefficients. c Correlation changes of A/B compartments with respect to the differences
between times, where the dashed line shares the same information as conveyed in the plot b.
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particularly DNA locations containing the JunB transcription
factor.
Correlating chromatin dynamics with gene expression. We next
went on to test whether these dynamic measures of DNA
activity, interaction and expression exhibited any correlation
between their time course profiles. Previous studies, using mea-
surements of H3K27ac, Hi-C and expression across different
cell types, demonstrated how subtle changes in contact
frequency correlated with larger changes in active DNA and
expression18. We wanted to determine the nature of this rela-
tionship in our data, from a single, activated cell type. We looked
for otherEnd baits that contained ATAC-seq peaks, and linked
these ATAC-seq peaks with CHi-C interactions to promoter baits
and associated genes. Using this approach, we formed 44,113
links. Pearson correlation coefficients for paired time course data
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Fig. 3 Illustration of ATAC-seq time course profile dynamics. a Heatmap of ATAC-seq counts data for peaks showing evidence of temporal dynamics.
b Clustering of ATAC-seq time course data using a Gaussian process mixture model. Significantly enriched DNA-binding MOTIFs in each peak (using static
peaks are background) are labelled in each cluster.
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and CHi-C were calculated. We used a link randomisation pro-
cedure to identify whether the number of correlations observed at
a particular level could be considered significantly enriched (see
“Methods”). We show an enrichment for extreme correlations
between ATAC-seq, CHi-C and RNA-seq data sets, particularly
an enrichment for high positive correlations within 200 kb of
promoters (Fig. 4a), suggesting that functional, interactive cor-
relations are most common within ‘contact domains’. This
observation is supported by previous findings, where the median
distance between H3K27ac loop anchors and interacting other-
Ends (130 kb)5 and the median distance of cohesion constrained
regulatory DNA-loops (185 kb)7 are typically within a ~200 kb
range.
Boxplots of the log fold change in ATAC-seq, CHi-C and
RNA-seq intensity in the highly correlated regions (Fig. 4b, c)
revealed how relatively small changes in both ATAC-seq and
CHi-C intensity (~2 fold change) correlated with larger changes
in expression (~5 fold change). This is consistent with similar
patterns observed in different cell types18.
Previous studies have indicated how using (1) eQTL data,
~50% of ATAC-seq peaks are already active/poised before
influencing gene expression19, (2) HiChIP data, expression can
be correlated with either H3K27ac or interactions5, and (3)
empirical ranking of enhancers by CRISPR corresponds most
strongly when combining terms for interaction and activity20.
Taken together, these observations suggest that both interactions
and activity have important roles in gene regulation. Examining
the relationship of CHi-C interactions, DNA dynamics and
expression in closer detail in our data with 200 kb distance
between bait and otherEnd fragments revealed three broad
patterns of dynamics associated with four clustered gene
expression patterns (Supplementary Fig. 11): ~8% (577/6,892)
of links were associated with dynamic ATAC-seq peaks only
(Supplementary Fig. 11a, b), 29% (2014/6892) were associated
with dynamic CHi-C interactions only (Supplementary Fig. 11c,
d) and 5% (371/6892) were associated with dynamics in both
(Supplementary Fig. 11e, f). Our findings, together with previous
studies, therefore suggest that both activity and interactions are
independently important in gene regulation and that subtle
change in interaction and ATAC-seq intensity have a larger effect
on gene expression.
Prioritisation of causal genes in GWAS loci for autoimmune
disease. We identified 312 loci which contained an autoimmune
disease lead SNP that was highly correlated with a variant (r2 >
0.8) located within an ATAC-seq peak, which was itself inter-
acting and highly correlated with the expression of a gene
(Supplementary Data 1). These data highlight potential causal
SNP, ATAC-seq and gene relationships for autoimmune disease
risk in CD4+ T cells, confirming previous reports or providing
new evidence for genes such as PRKCQ, CD44, ETS1 and
ARID5B.
We next considered 80 of the 100 loci previously associated
with RA that attain genome-wide significance in European
ancestry GWAS meta-analysis21,22. For each locus, we con-
structed a 99% credible set of SNPs that accounted for 99% of the
probability of containing the causal variant. We found that 97%
(2131/2192) of RA-associated variants from our 99% credible
SNP sets lie within A compartments across all time points while
only 28 (1%) lie consistently within B compartments after
stimulation. Fifteen credible set SNPs were found in regions that
change between A and B over time. These included RA credible
set SNPs on chromosome 1, proximal to the TNFSF4 and
TNFSF18 genes, that were initially contained within an inactive B
compartment at 20 min and were then found in an A
compartment at 4 h (Supplementary Fig. 9d).
We next investigated whether we could map RA GWAS-
implicated ATAC-seq peaks to genes, identify the likely causal
SNPs within the peaks and determine a mechanism and direction
of effect through the correlated expression data. Genome-wide,
RA credible set SNPs signals were enriched (5–30 fold) in open
regions of chromatin, as expected. The strongest enrichment was
observed at 4 and 24 h post stimulation (Supplementary Fig. 12a),
where SNPs mapping to open regions of chromatin explained up
to 30% of the heritability of RA (Supplementary Fig. 12b). We
found that 43/80 GWAS loci contained 67 ATAC-seq peaks with
at least one RA credible set SNP SNP (98 SNPs in total) that
interacted and correlated with the expression of 168 genes, an
average of 2.5 genes per peak (Supplementary Fig. 13 and
Supplementary Data 2).
These data have the ability to limit the number of putative
causal SNPs/ATAC-seq peaks for each locus. The 43 loci with
ATAC-seq peaks that contain RA GWAS-associated SNPs have
5527 credible SNPs, which reduce down to 98 SNPs in 67 ATAC-
seq peaks that interact with and are correlated with the expression
of 168 genes. For example, there are 18 SNPs within the 99%
credible SNP set for the RBPJ locus, but this reduces to 2 SNPs
within 2 ATAC-seq peaks that interact and correlate with gene
expression (Supplementary Fig. 14a).
For six loci, interactions between 30 and 220 kb implicate
either a single ATAC-seq peak (CD5, PXK, TCTE1, CDK6,
TPD52) or two ATAC-seq peaks (IL6ST) that contain an RA
credible set SNP, interacting with the target eQTL gene. This
implicated a single likely causal SNP in three loci (PXK, CDK6,
TPD52, CD5) and less than three likely causal SNPs in the other
loci (IL6ST, TCTE1) (Supplementary Data 2).
For 13 loci, our correlated, dynamic data support the currently
assigned gene, and provide the first biological evidence for 7 of
these genes (Supplementary Data 2). These genes include DDX6,
PRKCH, RBPJ, PVT1, PRDM1 and PTPN2, with many interac-
tions confirming genes up to 200 kb, and one over 800 kb (PVT1),
from the RA credible set SNPs SNP, but always constrained
within TADs.
For a number of loci, our results point to complex relationships
between RA credible set SNP regions and putative causal genes
(Supplementary Data 2). For some regions, whilst we did not
demonstrate direct interaction between an ATAC-seq peak and
gene, the genomic region spanning the credible SNP set made a
long distance physical interaction with genes that have supportive
evidence for disease involvement. For example, on chromosome
10, an intronic region within the ARID5B gene, containing RA
credible set SNPs, interacts with RTKN2, involved in the NFKB
pathway, and containing nsSNPs associated with Asian RA23
(Supplementary Fig. 14b). Similarly on chromosome 3, a region
with RA credible set SNPs intergenic of EOMES interacts with
AZI2 (an activator of NFKB), suggesting the region contains an
enhancer that could potentially control two important genes in
the T-cell immune pathway (Supplementary Fig. 14c). We also
provide evidence for, complex regions with direct ATAC-seq,
gene promoter interactions. Two regions in particular provided
insight into potential target genes for RA. Two ATAC-seq peaks,
containing five SNPs that are RA credible set SNPs on
chromosome 8, both interact with PVT1 and MYC1, situated
some 450–800 kb away from these peaks (Fig. 5). Here we
demonstrate a positive correlation between the ATAC-seq peak
dynamics and gene expression for both PVT1 and MYC1 (r2=
0.67 and 0.68, respectively). Interestingly, this ATAC-seq peak
region has previously been demonstrated to be a key repressor of
MYC1 gene expression, following a comprehensive CRISPRi
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Fig. 4 Illustrations of the correlations between ATAC-seq, CHi-C and RNA-seq time course profiles. a Density plots of the Pearson correlation
coefficients between ATAC-seq and CHi-C, ATAC-seq and gene and gene and CHi-C under various distance ranges around promoters. Distances ranges
include those <5Mb, between 1 and 5Mb, between 500 kb and 1Mb, between 200 and 500 kb and <200 kb. Black lines represent the density plots of the
corresponding random background. P values from Wilcoxon tests are labelled in each panel with sample sizes of 27,805, 8229, 4742, 7942 and 6892 for
categories < 5Mb, 1–5Mb, 500 kb–1 Mb, 200–500 kb and <200 kb, respectively. b Comparison of the log2 fold change between CHi-C and gene data for
all data set (upper) and those highly correlated ones with Pearson correlation coefficients between ATAC-seq, gene and CHi-C over 0.5 (lower).
c Comparison of the log2 fold change between ATAC-seq and gene data for all data sets (upper) and those highly correlated ones with Pearson correlation
coefficients between ATAC-seq, gene and CHi-C over 0.5 (lower). Box plot shows the median, the interquartile range (IQR) and Turkey whiskers
(±1.5 times IQR).
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screen in K562 erythroleukemia cells20. We therefore confirm this
relationship between a distant regulatory region and MYC1
expression in primary T cells, highlighting the likelihood that this
gene has a role in the susceptibility to RA.
Putting this gene list through a drug target pipeline24
demonstrated how the newly implicated or confirmed genes
from this study, such as MyC, GSN and MMP9, are existing
therapeutic targets (Supplementary Table 2).
Confirmation of correlated interaction with CRISPR/Cas9.
Finally we sought to demonstrate how an ATAC-seq peak, con-
taining an RA credible set SNP, intronic of the COG6 gene
interacts with, and is correlated with the expression of, the
FOXO1 gene located some 900 kb away (Fig. 6). We investigated
whether this dynamic ATAC-seq peak is functionally interacting
with the FOXO1 promoter, a transcription factor involved in
T-cell development, and a gene that has previously been strongly
implicated in RA through functional immune studies in patient
samples25–28. To do this we used CRISPRa, with dCas9-p300, and
the HEK293T cell line. Although using a cell line, as opposed to
primary immune cells, is not optimal, we used HEK293T cells as
the model system since we and others have previously demon-
strated how the TAD region containing both COG6 and FOX01 is
highly conserved in a wide range of cell types, including primary
cells as well as various cell lines (Jurkat, GM and HEK293T). We
designed guide RNAs (gRNAs) to cover the single enhancer that
contains the two ATAC-seq peaks and three RA credible set
SNPs, pooling the guides in a single transfection (Supplementary
Fig. 15). We demonstrated that, when we activate the COG6
intronic enhancer with this system and targeted gRNAs, not only
do we observe a consistent increase in COG6 mRNA expression
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Fig. 5 Illustration of genomic interaction activities around MYC. a Screenshot of the SNPs (dark green), ATAC-seq peaks (red), RNA-seq (lightblue),
CHi-C interactions (green) and heatmap from Hi-C (purple) around MYC at time 4 h. y-axis labels A–J represent different tracks plotted. A RefSeq genes, B
TADs, C Index SNPs, D LD SNPs, E 99% credible sets, F ATAC-seq peaks, G ATAC-seq signal, H RNA-seq, I CHi-C, J Hi-C. b Time course profiles of
ATAC-seq (left), CHi-C (middle) and RNA-seq (right) of the data associated with SNPs data around MYC.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18180-7
8 NATURE COMMUNICATIONS |         (2020) 11:4402 | https://doi.org/10.1038/s41467-020-18180-7 | www.nature.com/naturecommunications
gene expression (Fig. 7). Although the credible set SNP in this
region is a strong eQTL for COG6, this CRISPR validation of the
correlated interaction, DNA activity and expression data, along-
side previous immunological studies, implies that the associated
enhancer may have diverse roles on a number of genes within this
1 Mb TAD region, and that GWAS-implicated enhancers should
not necessarily be assigned to single genes.
Discussion
We have generated a unique, high-quality, high-value resource,
correlating a range of dynamic data, to inform the assignment of
regulatory regions to genes. This analysis adds to the growing
evidence that the relationship between enhancers and promoters
is complex, that interactions are more strongly correlated within a
distance of 200 kb and that they are mostly constrained
within TADs.
Using CD4+ T cells, stimulated with anti-CD3/anti-CD28, we
analyse ATAC-seq, RNA-seq, Hi-C and CHi-C over 24 h. Time
points were selected to understand how chromatin changes in the
very early stages after stimulation, and how GWAS associated
variants for autoimmune diseases, in particular RA, map to these
chromatin dynamics. We show that the conformation of the DNA
at a higher structural level of A/B compartments29 and TADs30
remains relatively constant throughout the stimulation time course.
In contrast, DNA interactions at the level of discrete contacts, for
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Fig. 6 Illustration of genomic interaction activities around FOXO1. a Screenshot of the SNPs (dark green), ATAC-seq peaks (red), RNA-seq (lightblue),
CHi-C interactions (green) and heatmap from Hi-C (purple) around FOXO1 at time 4 h. y-axis labels A–J represent different tracks plotted. A RefSeq genes,
B TADs, C Index SNPs, D LD SNPs, E 99% credible sets, F ATAC-seq peaks, G ATAC-seq signal, H RNA-seq, I CHi-C, J Hi-C. b Time course profiles of
ATAC-seq (left), Chi-C (middle) and RNA-seq (right) of the data associated with SNPs data around FOXO1.
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dynamic post stimulation, with over 30% of individual interactions
showing some degree of change over 24 h; however, only a min-
ority of these changes are correlated with a change in expression.
These results suggest that ATAC-seq peaks are associated with two
CHi-C interactions on average, with each gene making contact
with 7.7 ATAC-seq peaks on average. Although this correlation
can occur over large distances (up to 5Mb in our data), it is
strongly enriched within 200 kb. We also demonstrate how subtle
changes in both ATAC-seq and interaction intensity can have
more marked effects on gene expression. These data therefore
suggest that, when assigning GWAS variants to putative causal
genes, all genes within 200 kb, all within the TAD structure and
multiple causal genes should be considered as candidates for
functional validation. In addition, as a proof of principle, we have
confirmed one long range (~1Mb) gene target using CRISPR/Cas9.
Marks for active enhancers (H3K27ac and H3K4me1) are highly
enriched in both all ATAC-seq peaks and those interacting with a
gene promoter. However, since CTCF sites are also enriched under
these ATAC-seq peaks, this does not exclude the possibility that
these are involved in the dynamics of the data.
We also implicate genes in RA-associated loci not previously
highlighted as likely causal from GWAS, most notably MYC and
FOXO1. MYC is a proto-oncogene transcription factor, involved
in pro-proliferative pathways, highly expressed in a wide range of
cancers. It has long been known that this gene is expressed in the
RA synovium31,32, potentially playing a role in the invasiveness of
these cells. More notably for this study, it has recently been
demonstrated how a CD4+ T-cell subset from RA patients
demonstrates higher autophagy, and that MYC is a central reg-
ulator of this pathway. Here it was suggested that autophagy
could contribute to the survival of inflammatory T cells in
patients, particularly a pathogenic-like lymphocyte (CPL) subset,
found in inflamed joints and associated with disease activity.
Similarly FOXO1 has long been established to be downregulated
in both synovium and blood from RA patients, and is also cor-
related with disease activity27. FOXO1 is a transcription factor,
thought to play a role in apoptosis and cell cycle regulation, where
reduced expression in RA is suggested to have a role in the
accumulation of fibroblasts in the disease synovium27. In this
study, for both these genes with established biological mechan-
isms and expression patterns relevant to RA, we have demon-
strated how genetic variants that lead to an increased risk of
developing disease are physically linked and correlated with gene
expression, providing evidence that these genes may be causal
instigators in disease, and not simply on the pathways that are
dysregulated in disease.
Our results indicate that: (1) both DNA activity and interaction
intensity are independently important in the regulation of genes;
and (2) since a minority of interactions correlate with gene
expression, simply assigning target genes by interactions is too
simplistic. Instead, other methods, such as the simultaneous
measurement of DNA activity and expression data followed by
CRISPR experimental validation, are required to confidently
assign genes to GWAS-implicated loci. Finally, we confirm that
subtle changes in interaction intensity are correlated with much
larger changes to gene expression. In combination these findings
have important implications for fully exploiting GWAS data,
assigning causal SNPs, genes, cell types and mechanism to trait
associated loci, on the pathway to translating these findings into
clinical benefit.
Methods
Isolation of CD4+ T cells and stimulation time course. Primary human CD4+
T cells were isolated from peripheral blood mononuclear cells (PBMCs) and col-
lected from three healthy individuals with informed consent and ethical approval
(Nat Rep 99/8/84). PBMCs were initially isolated using Ficoll density gradient
centrifugation. CD4+ T cells were isolated from 100 million PBMCs by negative
selection using the EasySep Human T-cell isolation kit (StemCell Technologies,
catalogue #17952) according to the manufacturer’s instructions. Flow cytometry
analysis was used to confirm a high level of purity of CD4+ T cells (Supplementary
Fig. 2a).
For flow cytometry, samples were collected on a BD LSR Fortessa X-20, using
SYTOX red (Thermo Fisher Scientific) to discriminate against dead cells and
monoclonal antibodies against CD3 and CD4 to establish purity (CD3, OKT3
dilution 1/50; CD4, OKT4, dilution 1/100; Biolegend). The gating strategy for a
representative sample is shown (Supplementary Fig. 2b). Acquisition data were
analysed using FlowJo 10.6.1 (BD).
Isolated CD4+ T cells were plated in six-well plates then stimulated with
anti-CD3/anti-CD28 Dynabeads (Life Technologies) over a period of 24 h, with
samples removed at the appropriate time point and processed according to the
experiment the cells would be used for. Unstimulated samples were also
prepared (t= 0 sample). For Hi-C experiments, CD4+ T cells (8–10 million)
were harvested and fixed in formaldehyde, samples for RNA-seq (5 million CD4
+ T cells) were stored in RNA CellProtect reagent before extraction and samples
for ATAC-seq (50,000 cells) were processed immediately. ATAC-seq samples
from three individuals were taken at time 0 min, 20 min, 1 h, 2 h, 4 h and 24 h.
Two pooled nuclear RNA-seq replicates were taken at the same time points as
ATAC-seq samples. Two pooled Hi-C and CHi-C replicates were taken at 0 min,
20 min, 1 h and 4 h and one sample for Hi-C and CHi-C was taken at 24 h,
respectively.
Library generation for CHi-C and Hi-C. To generate libraries for Hi-C experi-
ments, 8–10 million CD4+ T cells were harvested at the appropriate time point
and formaldehyde crosslinking carried out as described in Belton et al.33. Cells were
washed in Dulbecco’s modified Eagle’s medium (DMEM) without serum then
crosslinked with 2% formaldehyde for 10 min at room temperature. The cross-
linking reaction was quenched by adding cold 1M glycine to a final concentration










































































Fig. 7 CRISPR dCAS9 activation (CRISPRa) targeting of an RA-associated variant. The region around an associated RA variant (rs9603616) on
chromosome 13 intronic of the COG6 gene was targeted in the HEK2937T cell line, using p300 as the activator. a Fold change (qPCR) effect on FOXO1
gene expression compared to negative control. b Fold change (qPCR) effect on COG6 gene expression compared to negative control.
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cells were washed in ice-cold PBS, the supernatant discarded and the pellets flash-
frozen on dry ice and stored at −80 °C.
Hi-C libraries were prepared from fixed CD4+ T cells from three individuals
that were pooled at the lysis stage to give ~30 million cells. Cells were thawed on ice
and re-suspended in 50 ml freshly prepared ice-cold lysis buffer (10 mM Tris-HCl
pH 8, 10 mM NaCl, 0.2% Igepal CA-630, one protease inhibitor cocktail tablet).
Cells were lysed on ice for a total of 30 min, with 2 × 10 strokes of a Dounce
homogeniser 5 min apart. Following lysis, the nuclei were pelleted and washed with
1.25xNEB Buffer 2 then re-suspended in 1.25xNEB Buffer 2 to make aliquots of
5–6 million cells for digestion. Following lysis, libraries were digested using HindIII
then prepared as described in van Berkum et al.34 with modifications described in
Dryden et al.35. Final library amplification was performed on multiple parallel
reactions from libraries immobilised on Streptavidin beads using eight cycles of
PCR using CHiC_TruPE_PCR primers (Supplementary Table 3) if the samples
were to be used for CHi-C, or 6 cycles using the TruSeq_Universal and Indexed
primers (Supplementary Table 3) for Hi-C. Reactions were pooled post-PCR,
purified using SPRI beads and the final libraries re-suspended in 30 µl TLE. Library
quality and quantity were assessed by Bioanalyzer and KAPA qPCR prior to
sequencing on an Illumina HiSeq2500 generating 100 bp paired-end reads
(Babraham sequencing facility).
Solution hybridisation capture of Hi-C library. Pre-CHi-C libraries corre-
sponding to 750 ng were concentrated in a Speedvac then re-suspended in 3.4 μl
water. Hybridisation of SureSelect custom capture libraries to Hi-C libraries was
carried out using Agilent SureSelectXT reagents and protocols. Post-capture
amplification was carried out using eight cycles of PCR using the TruSeq_Universal
and Indexed primers (Supplementary Table 3) from streptavidin beads in multiple
parallel reactions, then pooled and purified using SPRI beads. Library quality and
quantity was assessed by Bioanalyzer and KAPA qPCR prior to sequencing on an
Illumina HiSeq2500 generating 100 bp paired-end reads (Babraham sequencing
facility).
Defining regions of association for bait design. All independent lead disease-
associated SNPs for RA were selected from both the fine-mapped Immunochip
study21 and a trans-ethnic GWAS meta-analysis22. This resulted in a total of 138
distinct variants associated with RA after exclusion of HLA-associated SNPs.
Associated regions were defined by selecting all SNPs in LD with the lead disease-
associated SNP (r2 ≥ 0.8; 1000 Genomes phase 3 EUR samples; May 2013). In
addition to the SNP associations, credible SNP set regions were defined for the
Immunochip array at a 95% confidence level.
Target enrichment design. Capture oligos (120 bp; 25–65% GC, <3 unknown (N)
bases) were designed to selected gene promoters (defined as the restriction frag-
ments covering at least 500 bp 5′ of the transcription start site (TSS)) using a
custom Perl script within 400 bp but as close as possible to each end of the targeted
HindIII restriction fragments and submitted to the Agilent eArray software (Agi-
lent) for manufacture. Genes were selected as follows: all genes within 1 Mb
upstream and downstream of associated RA SNPs from Eyre et al.21 and Okada
et al.22 as previously described; all gene promoters showing evidence of interacting
with an associated region in our previous CHi-C study using GM12878 and Jurkat
cell lines; all genes contained within the KEGG pathways for ‘NF-kappa B sig-
nalling’, ‘Antigen processing and presentation’, ‘Toll-like receptor signalling’, ‘T cell
receptor signalling’ and ‘Rheumatoid arthritis’; all genes showing differential
expression in CD4+ T cells after stimulation with anti-CD3/anti-CD28; all genes
from Ye et al.4 within the ‘Early induced’, ‘Intermediate induced I’ and ‘Inter-
mediate induced II’ categories; and all genes from the Ye et al.4 NanoString panel.
Additionally control regions targeting the HBA, HOXA and MYC loci were
included for quality control purposes.
Library generation for RNA-seq. Nuclear RNA-seq was used to quantify nascent
transcription to determine changes through time. Five million CD4+ T cells were
harvested, stored in Qiagen RNAprotect solution and the nuclear RNA isolated.
Briefly, cells were thawed and centrifuged at 5000 × g for 5 min then the pellet re-
suspended in 1 ml cold buffer RLN. RNA isolation was continued from this point
using Qiagen RNeasy kit reagents and protocol. Samples were either pooled in
equal amounts (same individuals as for Hi-C to create matched samples), or
processed individually to give duplicate samples. Libraries for RNA-seq were
prepared using the NEB Next Ultra Directional RNA-seq reagents and protocol
using 100 ng of nuclear RNA as Input. Library quality and quantity were assessed
by Bioanalyzer and KAPA qPCR prior to sequencing. Each library was sequenced
on half a lane of an Illumina HiSeq2500 generating 100 bp paired-end reads
(Babraham sequencing facility).
Library generation for ATAC-seq. ATAC-seq libraries were generated from
50,000 CD4+ T cells from three individual samples using the protocol detailed in
Buenrostro et al.36. Briefly, cells were pelleted at 500 × g for 5 min at 4 °C, the
supernatant was removed and the cells were lysed in 50 μl cold lysis buffer (10 mM
Tris-HCl pH7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% Igepal CA-630). Immediately
following the lysis reaction, the samples were centrifuged at 500 × g for 10 min at
4 °C, the supernatant was discarded and the cells were kept on ice.
The transposition reaction was carried out using Illumina Nextera DNA Sample
Preparation Kit reagents. Cells were re-suspended in 10 μl 2x reaction buffer (TD),
2.5 μl transposase (TDE1) and 7.5 μl nuclease-free water and then incubated at
37 °C for 30–45 min in a thermomixer. Samples were purified using Qiagen
MinElute columns following the manufacturer’s protocol, eluting in 10 µl. PCR was
performed for ten cycles using Nextera dual indexing primers under the following
conditions: 72 °C 5 min; 98 °C 30 s; ten cycles of 98 °C 10 s, 63 °C 30 s, 72 °C for
1 min. PCR products were purified using Qiagen MinElute columns following the
manufacturer’s protocol, eluting in 20 µl. Library quality and quantity were
assessed by Bioanalyzer and KAPA qPCR prior to sequencing. Each library was
sequenced on half a lane of an Illumina HiSeq2500 generating 100 bp paired-end
reads (Babraham sequencing facility, Cambridge).
Hi-C data processing. Hi-C data were mapped to GRCh38 by HiCUP37. The
maximum and minimum di-tag lengths were set to 800 and 150, respectively.
HOMER38 Hi-C protocol was applied to Hi-C bam file and normalised Hi-C
matrices were generated by analyzeHiC command from HOMER with resolution
of 40,000 bp (analyzeHiC –res 40,000 –balance). TADs were generated by the
command findTADsAndLoops.pl (–res 40,000). A/B compartments were generated
by runPCA.pl (–res 40,000) followed by findHiCCompartments.pl with the default
parameters to generate compartments A and –opp parameters to generate
compartments B.
CHi-C data processing. CHi-C data were mapped to GRCh38 by HiCUP. The
maximum and minimum di-tag lengths were set to 800 and 150, respectively.
CHiCAGO39 was applied to each bam file with the CHiCAGO score set to 0.
Counts data for each interaction were extracted from the .rds files generated by
CHiCAGO. Time course interactions were concatenated. Those interactions with
at least one time point having CHiCAGO score over 5 were kept. Bait-to-bait
interactions were registered as two interactions with either side defined as ‘bait’ or
‘otherEnd’.
ATAC-seq data processing. Individual ATAC-seq reads data were mapped to
GRCh38 by Bowtie240 (with option –x 2000) and reads with mapping quality lower
than 30 were filtered by SAMtools41. Duplications were removed by Picard (https://
broadinstitute.github.io/picard/). The three replicated bam files at each time point
were merged by SAMtools. MACS242 was applied on each merged bam file to call
peaks (with option –nomodel –extsize 200 –shift 100). Peaks generated from each
time point were merged by Diffbind43 with default parameter to form the time
course profile for ATAC-seq peaks.
RNA-seq data processing. RNA-seq data were mapped to GRCh38 by STAR13
with default parameters. Counts data for exons and introns were generated by
DEXSeq44. Individual counts data from each time point were combined to form the
time course gene expression data. Exons and introns counts data were summed to
get the gene expression data for each gene at each time point, respectively. Genes
with the sum of counts data across the six time points <10 were removed in each
replicate. Only genes that have expressions in both replicates were kept. In all,
22,126 genes remained after this processing.
Linking CHi-C, ATAC-seq and RNA-seq time course data. CHi-C time course
data were linked to RNA-seq time course data with baits design specifying the
mapping between baits and genes. ATAC-seq peaks residing at an otherEnd
fragment were correlated with CHi-C interactions originating from that specific
otherEnd fragment to different baits. Averaged data from replicates were used in
correlation analysis. Pearson correlation coefficients between the connected CHi-C,
gene and ATAC-seq time course data were calculated, respectively. Background
random correlation tests were carried out by randomly picking up relevant time
course data within the targeted data set without any restrictions and calculating
their Pearson correlation coefficients accordingly.
Gaussian process test for dynamic time course data. Time course data were
fitted by a Gaussian process regression model17 with a radial basis function kernel
plus a white noise kernel (dynamic model) and a pure white noise kernel (static
model), respectively. BIC was calculated for the dynamic model and flat model,
respectively (see the following equation):
BIC ¼ klnðnÞ  2lnðL̂Þ; ð1Þ
where k is the number of parameters used in the specified model, n is the sample
size and L̂ is the maximised likelihood for the model. Models with smaller BIC are
favoured for each time course profile. Those with smaller BICs in dynamic models
were classified as time varying. A more stringent χ2 test with degree of freedom
of 1 was also applied to the log-likelihood ratio (LR) statistics, with LR ¼
2lnðL̂RBF  L̂STATICÞ, where L̂RBF and L̂STATIC are the maximised likelihoods for
the Gaussian process model and a static model, respectively. A P value of 0.05 was
deemed significant.
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ATAC-seq data clustering and MOTIF searching. A more inclusive threshold of
LR < 1 was applied to ATAC-seq peaks prior to clustering, which leaves 16%
(12,215/74,583) ATAC-seq dynamical peaks, among which 9680 were outside
promoter regions ([+500 bp,−1000 bp] around genes). These ATAC-seq peaks
were clustered using a Gaussian process mixture model45. MOTIFs for each cluster
were searched by findMotifGenome.pl (–mask –len 5,6,7,8,9,10,11,12 –size given)
from HOMER with static peak data being used as background data.
Construction of 99% credible SNP sets for RA loci. We considered 80 loci
attaining genome-wide significance for RA in the European ancestry component of
the most recently published trans-ethnic GWAS meta-analysis22, after excluding
the MHC. For each locus, we calculated the reciprocal of an approximate Bayes’












where β and V denote the estimated log odds ratio and corresponding variance
from the European ancestry component of the meta-analysis. The parameter ω
denotes the prior variance in allelic effects, taken here to be 0.04. The posterior
probability of causality for the SNP is then obtained by dividing the Bayes’ factor
by the total of Bayes’ factors for all SNPs across the locus. The 99% credible set for
each locus was then constructed by: (1) ranking all SNPs according to their Bayes’
factor; and (2) including ranked SNPs until their cumulative posterior probability
of causality attained or exceeded 0.99.
Overlap between ATAC-seq peaks and autoimmune GWAS loci. Autoimmune
GWAS loci (defined by NCIT:C2889, OBI:OBI 1110054, OMIM:613551, OMIM:
615952, OMIM: 617006, SNOMEDCT:85828009) were downloaded from the
GWAS catalogue (https://www.ebi.ac.uk/gwas/efotraits/EFO_0005140 Accessed
July 2018) and SNPs with r2 ≥ 0.8 identified using PLINK v1.07. These were then
overlapped with ATAC-seq peaks linked to CHi-C genes, using bedtools v2.21.0, to
identify regions of open chromatin containing an autoimmune GWAS SNP SNP or
highly correlated variant.
RA heritability and enrichment. We performed RA SNP enrichment and herit-
ability estimates in the ATAC peaks identified throughout the time course. This
was performed using partitioned heritability analysis from the LD score regression
software47 and European ancestry data from the latest RA GWAS meta-analysis21.
Briefly, the heritability of RA and SNP enrichments is computed in partitioned
sections of the genome, in this case, the ATAC-seq peaks at each time point.
CRISPR activation using dCas9-p300. Cell lines: HEK293T cells (Clontech) were
cultured in high glucose-containing Dulbecco’s modified Eagle’s medium (Sigma)
supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C/5% CO2 and
kept below passage 15.
Generation of the dCas9-p300 cell line and delivery of guides: HEK293T cells
were first transduced lentivirally with the pLV-dCas9-p300-p2A-PuroR expression
vector (Addgene #83889) and were selected with 2 µg mL−1 of puromycin and
cultured for a week before being banked as a cell line. A second round of lentiviral
transduction was performed to introduce the gRNA using the vector pLK05.
sgRNA.EFS.GFP (Addgene #57822) and cells were doubly selected using both a
maintenance selection of puromycin and sorted for the top 60% cells
expressing GFP.
Guide RNAs. All gRNAs were cloned into the guide delivery vector pLK05.sgRNA.
EFS.GFP (Addgene #57822). A negative control guide Scr2 (AACAGTCGCGTT
TGCGACT) is a scrambled guide sequence for comparison of gene expression that
is not expected to target any known genes in the genome. A positive control guide
IL1RN (CATCAAGTCAGCCATCAGC) was included, this is a guide directed to
the TSS of the promoter of the IL1RN gene that has been previously shown to
increase expression of the IL1RN gene substantially48. For the COG6/FOX01, locus
three guides (TGGGGACTATCTAGCTGCT; AGGGCCTTATAATGTAGT;
AGTCATCCTGGAGCACAGAGG) were pooled simultaneously in equimolar
amounts to target the active enhancer marked by H3K27ac in proximity to the lead
GWAS variant rs7993214.
Lentivirus production. The day before transduction HEK293T cells were seeded at
a density of 10 million cells per transfer vector in 15 cm plates in a volume of 20 ml
of DMEM 10% FBS without penicillin/streptomycin. Each of the transfer vectors,
together with packaging plasmids pmDLg/pRRE (#12251) and pRSV-REV
(#12253) along with envelope plasmid pMD2.G (#12259), were combined to a total
of 12 µg at a ratio of 4:2:1:1, respectively, in 2 ml of serum free DMEM without
phenol red.
PEI 1 mgmL−1 was batch tested and added at a ratio of 6:1 PEI: DNA. The
solution was briefly vortexed and incubated at room temperature for 15 min.
Following this the solution was added dropwise to the cells. Flasks were rocked
gently in a circular motion to distribute the precipitates, and then returned to the
incubator. Twenty-four hours later fresh DMEM supplemented with 10% FBS and
1% penicillin/streptomycin was added. The viral supernatant was collected 72 h
after transduction, cleared by centrifugation at 500 × g for 5 min at 4 °C then passed
through a 0.45 µm pore PVDF Millex-HV (Millipore). Lentivirus was aliquoted and
stored at −80 °C for future use.
Transduction of HEK293T p300 cell line with the gRNAs. dCas9-p300-
HEK293T cells were plated at 3 × 105 cells mL−1 onto six-well plates in triplicate for
each gRNA. Twenty-four hours later the medium was replaced with DMEM 10%
FBS without penicillin/streptomycin. 1 ml of each gRNA generated lentivirus was
added to each well. Twenty-four hours later the medium was changed to DMEM
containing 10% FBS and 1% penicillin/streptomycin. Cells were cultured for 5 days
and then sorted for the top 60% of cells expressing GFP using flow cytometry.
RNA extraction and qPCR. When confluent 2 × 106 cells were centrifuged at
400 × g for 5 min and washed in PBS. RNA was extracted using the RNeasy mini kit
(Qiagen) according to manufacturer’s instructions and the genomic DNA removal
step was included. 100 ng of RNA for each sample was used in a single RNA-to-Ct
reaction (Thermo Fisher) to assay gene expression. Taqman assays for FOX01
(Hs00231106_m1), COG6 (Hs01037401_m1) and IL1RN (hs00893626_m1) were
used alongside housekeeping genes YWHAZ (Hs01122445_g1) and TBP
(hs00427620_m1) for normalisation.
Data analysis. Delta-delta CT analysis was carried out using the Scr2 generated
dCas9-p300 HEK293T cells as the control and normalised against the YWHAZ and
TBP housekeeping genes. The data were analysed in graph pad using one-
way ANOVA.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Raw sequencing data and processed counts data for ATAC-seq, RNA-seq, CHi-C and
Hi-C that support the findings of this study have been deposited in National Center for
Biotechnology Information’s Gene Expression Omnibus and are accessible through GEO
Series accession number GSE138767. The full data are accessible using the following link:
http://epigenomegateway.wustl.edu/legacy/?genome=hg38&datahub=http://bartzabel.ls.
manchester.ac.uk/worthingtonlab/functional_genomics/GSE138767/GSE138767.json. All
other relevant data supporting the key findings of this study are available within the
article and its Supplementary Information files or from the corresponding author upon
reasonable request. The source data underlying Figs. 2–4, 5b, 6b, 7 and Supplementary
Figs. 1–8, 10–12 are openly available in repository Zenodo, with https://doi.org/10.5281/
zenodo.3899030.
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